Hasil Pencarian  ::  Simpan CSV :: Kembali

"Latar belakang. Displasia bronkopulmonal (DBP) adalah penyakit multifaktorial kronis akibat inflamasi baik prenatal maupun postnatal. Hal ini akan menyebakan komplikasi jangka panjang dalam hal pernapasan, kardiovaskuler, dan neurodevelopmental. Azitromisin sebagai agen antiinflamasi diharapkan dapat mencegah kejadian DBP.Metode. Uji klinis acak terkontrol tidak tersamar dilakukan selama Juni 2021-April 2022 di unit Neonatologi RSCM Jakarta pada 114 subjek dengan usia gestasi 25 minggu-31 minggu 6 hari yang mengalami distress napas. Pasien yang memenuhi kriteria inklusi dan eksklusi dilakukan randomisasi dan dibagi menjadi dua kelompok yaitu kelompok uji/perlakuan dan kelompok kontrol, masing masing sebanyak 57 subjek. Kelompok uji akan mendapatkan azitromisin dalam usia <24 jam selama 14 hari dengan dosis 10 mg/kgbb/intravena selama 7 hari kemudian dilanjutkan 5 mg/kgbb/intravena selama 7 hari. Pasian akan dipantau sampai dengan usia gestasi 36 minggu untuk melihat outcome primer berupa DBP, dan outcome sekunder berupa IVH, PVL, EKN, lama penggunaan O2, durasi penggunaan ventilator mekanik, lama pencapaian full enteral feeding, serta mortalitas pada kedua kelompok. Diagnosis DBP ditegakkan berdasarkan NICHD 2019.Hasil. Angka kejadian DBP secara umum adalah 34.8%. Angka kejadian DBP pada bayi extremely preterm adalah 58.3%, sedangkan pada bayi very preterm adalah 31%. Kejadian DBP lebih banyak pada kelompok kontrol (63% vs 38%) dengan RR 0.611(0.417-0.896). Durasi penggunaan ventilator mekanik lebih pendek pada kelompok yang mendapatkan azitromisin (5.22 vs 12.75,p 0.025). Lamanya pencapaian full enteral feeding lebih pendek pada kelompok uji/perlakuan (13.38 vs 17.14 hari, p 0.04). Angka kejadian EKN lebih rendah pada kelompok uji/perlakuan (19% vs 40%, nilai p 0.014). Mortalitas lebih rendah pada kelompok uji/perlakuan (25% vs 46% , nilai p 0.019) RR 1.660 (95% CI 1.043-2.642). Kesimpulan. Azitromisin dapat menurunkan angka kejadian DBP, mempercepat pencapaian full enteral feeding, menurunkan mortalitas pada bayi prematur.

---

Background. Bronchopulmonary dysplasia (BPD) is a chronic multifactorial disease caused by inflammation both prenatal and postnatal. This will lead a long-term complications of respiratory, cardiovascular, and neurodevelopmental. Azithromycin as an antiinflammatory agent is expected to prevent BPD.

Methods. A randomized controlled clinical trial, unblinded was conducted during June 2021-April 2022 at the Neonatology unit of RSCM Jakarta on 114 subjects with a gestational age of 25 weeks-31 weeks 6 days who experienced respiratory distress. Patients who met the inclusion and exclusion criteria were randomized and divided into two groups, the intervention group and the control group, each group with 57 subjects. The intervention group will receive azithromycin at the age of <24 hours for 14 days at a dose of 10 mg/kg/intravenous for 7 days then followed by 5 mg/kg/intravenous for 7 days. Patients will be monitored up to 36 weeks' gestation to see the primary outcome in the form of BPD, and secondary outcomes in the form of IVH, PVL, EKN, duration of O2 used, duration of mechanical ventilator used, duration of achieving full enteral feeding, and mortality in both groups. BPD diagnosed based on NICHD 2019.

Results. The incidence of BPD in general is 34.8%. The incidence of BPD in extremely preterm infants is 58.3%, while in very preterm infants it is 31%. The incidence of BPD was more in the control group (63% vs 38%) with an RR 0.611(0.417-0.896). The duration of ventilator mechanic used was shorter in the intervention group (5.22 vs 12.75, p 0.025). The duration of achieving full enteral feeding was shorter in the intervention group (13.38 vs 17.14 days, p 0.04). The incidence of NEC was lower in the intervention group (19% vs 40%, p-value 0.014). Mortality was lower in the intervention group (25% vs 46%, p 0.019) RR 1.660 (95% CI 1.043-2.642).

Conclusion. Azithromycin can reduce the incidence of BPD, accelerate the achievement of full enteral feeding, reduce mortality in premature infants"

"Latar belakang : Jumlah kelahiran hidup bayi prematur di RSCM adalah 507 dan 112 diantaranya lahir pada usia gestasi 28-32 minggu atau disebut bayi baru lahir sangat prematur (BBLSP). Data RSCM menunjukkan bahwa BBLSP memiliki angka kesintasan 58,9%. Pemberian nutrisi yang agresif dengan diet tinggi protein pada BBLSP diperlukan untuk mempercepat kejar tumbuh. Diet tinggi protein memberikan beban metabolisme pada ginjal BBLSP yang sedang berkembang. Ginjal BBLSP memiliki jumlah nefron fungsional yang lebih sedikit dan imaturitas yang ditandai dengan rendahnya laju filtrasi glomerulus serta kemampuan pemekatan urin yang rendah. Diet tinggi protein menginduksi hipertrofi ginjal, proteinuria, dan sklerosis glomerular melalui single nephron glomerular hyperfiltration (SNGHF) sehingga menyebabkan cedera glomerulotubular yang dapat dideteksi dengan biomarka Neutrophil gelatinase-associated lipocalin urin (uNGAL). Tujuan : Mengetahui pengaruh asupan protein terhadap cedera glomerulotubular pada BBLSP. Metode : Penelitian ini adalah penelitian pada BBLSP yang dilakukan dengan desain kohort prospektif yang dilakukan di ruang rawat perinatologi Departemen Ilmu Kesehatan Anak RS Cipto Mangunkusumo dan RS Bunda Menteng pada periode 1 Juni 2019 hingga Mei 2020. Pengambilan sampel urin dilakukan sebanyak 3 kali yaitu usia 0-48 jam (T1), 72 jam (T2), dan usia 21 hari (T3). Dilakukan pemeriksaan rasio NGAL dan kreatinin urin (uNGAL/Cr). Cedera glomerulotubular didefinisikan sebagai uNGAL/Cr  1 SB. Data karakteristik subyek dan asupan protein diambil dari rekam medik. Rerata asupan protein enteral dicatat sejak usia 14-21 hari sesuai asupan di rekam medik. Kadar protein di ASI diukur dengan human milk analyzer. Asupan tinggi protein adalah kadar asupan protein 3 g/kg/hari. Hasil : Total subyek penelitian adalah 59 BBLSP pada saat rekruitmen dan terdapat 39 subyek menyelesaikan penelitian hingga usia 21 hari. Proporsi BBLSP yang mengalami cedera glomerulotubular pada pemberian kadar asupan tinggi protein 5/29 subyek, sedangkan pada pemberian kadar asupan rendah protein adalah 4/10 subyek. Kadar uNGAL/Cr pada BBLSP yang mendapatkan kadar asupan tinggi protein dibandingkan rendah protein adalah 3,54 (0,69-89,16) ng/mg dan 6,88 (0,32-66,64) ng/mg. Kadar uNGAL/Cr pada usia 48 jam, 72 jam, dan 21 hari tidak menunjukkan korelasi yang bermakna dengan kadar asupan protein (p=0,80; 0,58; 0,07).Simpulan : Sebanyak 5/29 subyek yang mendapatkan kadar asupan tinggi protein mengalami cedera glomerulotubular. Kadar uNGAL/Cr pada BBLSP yang mendapat asupan tinggi protein maupun rendah protein cenderung meningkat pada usia 72 jam dan menurun pada usia 21 hari. Pemberian asupan tinggi protein pada BBLSP tidak menyebabkan cedera glomerulotubular pada bayi sangat prematur.

---

Background: Absolute preterm birth rate in Cipto Mangunkusumo Hospital (CMH) was 507 in 2018, 112 amongst were born very preterm (28-32 weeks of gestational age). The survival rate was approximately 58.9%. Early aggressive nutrition by administration of high protein intake is needed for catch up growth. High protein produces high metabolic load to the kidney. Kidney in the very preterm neonates have fewer amount of functional nephron. Furthermore, the immaturity of the kidney was shown in lower glomerular filtration rate and ability to dilute urine. High protein intake induces nephron hypertrophy,

proteinuria, and glomerular sclerosis through single nephron glomerular hyperfiltration (SNGHF) which lead to glomerulotubular injury. Urine neutrophil gelatinase-associated lipocalin to creatinine ratio (uNGAL/Cr) is a biomarker used to detect glomerulotubular injury.

Aim : To analyze the correlation of high protein intake and glomerulotubular injury in very preterm neonates.

Method: A prospective cohort study was conducted in very preterm infants admitted to neonatology ward of CMH and Bunda Hospital Menteng during 1 June 2019 to May 2020. Urine sample were taken in 3 points of time: age 0-48 hours, 72 hours, and 21 days postnatal. Urine NGAL and creatinine (uNGAL/Cr) were examined. Glomerulotubular injury was defined as uNGAL/Cr level 1 SD. Subject characteristic data and protein intake were obtained from medical record. Enteral protein intake was recorded daily from medical record since age 14-21 days postnatal. Protein level in the breastmilk was measured by using human milk analyzer. High protein intake is recorded if the average intake was  3/kg/day.

Results: This study recruited 59 very preterm neonates and 39 of them survived until the end of the study. Proportion of very preterm neonates who had glomerulotubular injury after high protein intake vs low protein intake was 5/29 vs 4/10 subjects. Median of uNGAL/Cr level in high protein intake group compare to low protein intake group were 3,54 (0,69-89,16) ng/mg and 6,88 (0,32-66,64) ng/mg. Protein intake is not correlated to uNGAL/Cr level at 0-48 hours, 72 hours, and 21 days postnatal age (p=0,80; 0,58; 0,07).

Conclusion: There were 5/29 subjects experienced glomerulotubular injury in high protein intake administration. In very preterm neonates, uNGAL/Cr level was increased at the age of 72 hours and decreased in 21 days on both high and low protein intake group. High protein intake had no correlation to glomerulotubular injury in the very preterm neonates. "

"Latar Belakang: Bayi sangat prematur rentan terjadi retriksi pertumbuhan ekstrauterin yang berakibat gangguan neurodevelopmental. Hal ini dapat dicegah denganpemberian nutrisi parenteral agresif dini dan nutrisi enteral sesuai protokol nutrisibayi prematur. Tujuan pemberian nutrisi parenteral agresif dini adalah mencegahterjadinya katabolisme dan menjamin pertumbuhan yang sama dengan intrauteri.Pengukuran kecepatan pertumbuhan adalah salah satu metode pengukuranpertumbuhan untuk menilai status nutrisi pada bayi prematur. Nilai kecepatanpertumbuhan diukur pada usia 28 hari dikarenakan pada saat ini telah terjadipertumbuhan pesat setelah bayi kembali ke berat lahir.Tujuan: Mengetahui nilai kecepatan pertumbuhan usia 28 hari bayi sangat prematurdan atau bayi berat lahir sangat rendah serta faktor-faktor yang memengaruhinyasetelah mendapatkan protokol standar nutrisi bayi prematur yang berlaku di RSCM.Metode: Studi kohort prospektif dengan metode konsekutif sampling pada bayisangat prematur dan atau bayi berat lahir sangat rendah yang lahir di RSCM padabulan Februari sampai dengan November 2020.Hasil: Didapatkan 64 subjek penelitian yang diamati. Terdapat 33/64 (51,6%) subjekdengan transfusi berulang, 22/64 (34,4%) asidosis metabolik memanjang , 5/64(7,8%) EKN derajat II, 12/64 (18,8%) DAP Hs, 37/64 (57,8%) penyakit membranhialin derajat IV, 37/64 (57,8%) intoleransi minum, 55/64 (85,9%) SMK dan 9/64(14,1%) KMK. Rerata kecepatan pertumbuhan adalah 17,98 gram/kgBB/hari, SMK18,22 gram/kgBB/hari dan KMK 16,50 gram/kgBB/hari. Faktor yang palingmemengaruhi adalah asidosis metabolik memanjang dengan nilai p 0,01.Kesimpulan : Kecepatan pertumbuhan usia 28 hari bayi sangat prematur dan ataubayi berat lahir sangat rendah setelah mendapat protokol standar nutrisi bayiprematur RSCM adalah 17,98 gr/kgBB/hari. Asidosis metabolik memanjangmemengaruhi kecepatan pertumbuhan.

---

Background: Very preterm infants are susceptible to extrauterine growth restriction

resulting in neurodevelopmental disorders. This can be prevented by providing early

aggressive parenteral and enteral nutrition, aiming to prevent catabolism and ensure

similar intrauterine growth. Growth velocity is a growth measurement method for

assessing nutritional status in preterm infants, which is measured at 28 days of age

since it is the moment of rapid growth after the baby has returned to birth weight.

Aims : To determine the growth velocity at 28 days of age for very preterm and/or

very low birth weight infants and assess affecting factors in applying the standard

protocol of preterm infant nutrition in Cipto Mangunkusumo Hospital (CMH).

Methods: Prospective cohort study with consecutive sampling method on very

preterm and/or very low birth weight infants born in CMH since February to

November 2020.

Results: Among 64 subjects, the number of appropriate- and small-for-gestationalage

(AGA and SGA) were 55 (85.9%) and 9 (14.1%), respectively. The associated

conditions were as following; sepsis with repeated transfusions (33/64, 51.6%),

prolonged metabolic acidosis (22/64, 34.4%), grade II necrotizing enterocolitis (5/64,

7.8%), hemodynamically-significant patent ductus arteriosus (12/64, 18.8%), grade

IV hyaline membrane disease (37/64, 57.8%), and feeding intolerance (37/64,

57.8%). The mean growth velocity was 17.98 g/kg/day, specifically 18.22 g/kg/day

in AGA and 16.50 g/kg/day in SGA infants, respectively. The most influencing factor

in applying nutritional protocol was prolonged metabolic acidosis (p value = 0.01).

Conclusion: The growth velocity at 28 days of very preterm and/or very low birth

weight infants after receiving standard nutritional protocol for preterm infants in

CMH was 17.98 g/kg/day. Prolonged metabolic acidosis has significant influence on

growth velocity."